Every year, hundreds of new compounds are discovered from the metabolites of marine organisms. Finding new and useful compounds is one of the crucial drivers for this field of research. Here we describe the statistics of bioactive compounds discovered from marine organisms from 1985 to 2012. This work is based on our database, which contains information on more than 15,000 chemical substances including 4196 bioactive marine natural products. We performed a comprehensive statistical analysis to understand the characteristics of the novel bioactive compounds and detail temporal trends, chemical structures, species distribution, and research progress. We hope this meta-analysis will provide useful information for research into the bioactivity of marine natural products and drug development.

Breast cancer remains a major health problem worldwide. While chemotherapy represents an important therapeutic modality against breast cancer, limitations in the clinical use of chemotherapy remain formidable because of chemoresistance. The HER2/PI-3K/Akt pathway has been demonstrated to play a causal role in conferring a broad chemoresistance in breast cancer cells and thus justified to be a target for enhancing the effects of anti-breast cancer chemotherapies, such as adriamycin (ADR). Agents that can either enhance the effects of chemotherapeutics or overcome chemoresistance are urgently needed for the treatment of breast cancer. In this context, SZ-685C, an agent that has been previously shown, as such, to suppress Akt signaling, is expected to increase the efficacy of chemotherapy. Our current study investigated whether SZ-685C can override chemoresistance through inhibiting Akt signaling in human breast cancer cells. ADR-resistant cells derived from human breast cancer cell lines MCF-7, MCF-7/ADR and MCF-7/Akt, were used as models to test the effects of SZ-685C. We found that SZ-685C suppressed the Akt pathway and induced apoptosis in MCF-7/ADR and MCF-7/Akt cells that are resistant to ADR treatment, leading to antitumor effects both in vitro and in vivo. Our data suggest that use of SZ-685C might represent a potentially promising approach to the treatment of ADR-resistant breast cancer.

High power supercontinuum generation with 70 W average output power in a nonlinear ytterbium-doped fiber amplifier is demonstrated using all-normal dispersion, all-fiber master oscillator power amplifier configuration. The supercontinuum covers from 1064 nm to beyond 1700 nm with spectral flatness better than 12 dB and 67.3% optical to optical conversion efficiency. The almost uniform spectral power density across the whole continuum is more than 70 mW/nm and the nanosecond bursts output have an effective peak power of 82.7 kW.

No abstract

A high power picosecond laser is constructed in an all fiber master oscillator power amplifier (MOPA) configuration. The seed source is an ytterbium-doped single mode fiber laser passively mode-locked by a semiconductor saturable absorber mirror (SESAM). It produces 20 mW average power with 13 ps pulse width and 59.8 MHz repetition rate. A direct amplification of this seed source encounters obvious nonlinear effects hence serious spectral broadening at only ten watt power level. To avoid these nonlinear effects, we octupled the repetition rate to about 478 MHz though a self-made all fiber device before amplification. The ultimate output laser exhibits an average power of 96 W, a pulse width of 16 ps, a beam quality M2 of less than 1.5, and an optical conversion efficiency of 61.5%.